|By Marketwire .||
|December 26, 2012 02:05 PM EST||
NEW YORK, NY -- (Marketwire) -- 12/26/12 -- The global market for coronary stents is projected to recover from its recent decline due to new product innovations, exceeding $6 billion by 2017, according to a recent report from healthcare market research publisher Kalorama Information. Despite the generally difficult global economic climate and intense competition among stent manufacturers, the stent market is expected to grow in the next several years, although at a slower pace. In its new report, "The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)," Kalorama Information finds that market growth will result from an increase in the utilization of stents in interventional cardiology, fueled by a growing prevalence of coronary heart disease worldwide and the introduction of new improved devices to the market.
Several new technologies, such as bioresorbable stents, bifurcation and biodegradable polymers stents, are currently in development and projected to enter most major markets in the next years. Such new devices, especially the bioresorbable stents, have the potential to eliminate the negative issues of durable polymer stents, and are therefore expected to bring about a significant shift in the treatment of coronary heart disease, increasing the demand for stents.
"In particular, bioresorbable stents are expected to be welcomed in the treatment of coronary heart disease by both physicians and patients, substantially easing patients' discomfort of having a permanent metallic implant in their body," said analyst Adriana Rusu, author of this report.
According to the report, the first bioresorbable stent to reach the market was developed by Abbott Laboratories -- the leading player in the coronary stents market -- and launched in several markets, including Europe, in September 2012. Besides Abbott, several other companies are also developing bioresorbable stents, employing various technological approaches.
Kalorama Information's report, "The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)," examines in detail these new technologies, as well as the entire global coronary stents industry, its structure and major trends affecting it. Revenue forecasts at the global and regional level and profiles of various competitors are also included in the report.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
- "All It Took Was One E-Mail to Larry," Says Former eBay Research Director As He Moves to Google
- Google Ramps Up Its Mobile Reach: Launches "Mobile Web Search"
- VoIP Update: Yahoo! Buys DialPad
- Ericsson + Napster = World's First "Wireless Digital Music" Brand
- SYS-CON i-Technology Podcast August 30, 2005
- A Flair for Food - Health-Conscious Cooking Is This Chef's Cup Of Tea
- Sony PSP May Feature Porn
- Free Guest Passes for the SOA World Conference & Expo in NYC
- South Korea is World's Largest Phisher
- Kapow Helps Seiko UK, Provides SMS Text-Alert Services
- Will the Mac OS Now Be Offered by Dell?
- UK Targeted for Trojan Attacks